Arnerić, Stephen P.
Kern, Volker D.
Stephenson, Diane T.
Funding for this research was provided by:
U.S. Food and Drug Administration
This article is maintained by: Elsevier
Article Title: Regulatory-accepted drug development tools are needed to accelerate innovative CNS disease treatments
Journal Title: Biochemical Pharmacology
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.bcp.2018.01.043
Content Type: article
Copyright: © 2018 The Authors. Published by Elsevier Inc.